The European Commission decided on Tuesday to amend its second contract with the pharmaceutical company Moderna to purchase, on behalf of all member states, 150 million additional doses in 2022. EU countries can resell or donate doses to other countries outside the EU or through the COVAX vaccine-sharing scheme led by the World Health Organization. The EU has secured a total of 460 million doses of Moderna.